It was a pleasure to speak with our esteemed Editorial Board member and chair of the AAO annual meeting programme committee, Bennie Jeng (University of Maryland School of Medicine, Baltimore, MD, USA) about the impact of DSAEK, DMEK and DALK, and other emerging therapies for persistent corneal epithelial defects.
Questions:
- What impact have descemet stripping automated endothelial keratoplasty, descemet membrane endothelial keratoplasty and deep anterior lamellar keratoplasty had on corneal surgery?
 (00:12)
- Could you give us a brief overview of current and emerging therapies for persistent corneal epithelial defects?
 (02:06:
Speaker Disclosure: Bennie Jeng has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of AAO 2021.
